CVRx (CVRX) Preferred Stock Liabilities (2020 - 2021)
CVRx (CVRX) posted quarterly Preferred Stock Liabilities of $330.0 million for Q2 2021, up 17.86% year-over-year from $280.0 million in Q2 2020, and little changed quarter-over-quarter from $330.0 million in Q1 2021.
CVRx (CVRX) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
CVRx's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $330.0 million for Q2 2021.
- In Q2 2021, Preferred Stock Liabilities rose 17.86% year-over-year to $330.0 million; the TTM figure through Jun 2021 stood at $330.0 million (up 17.86% YoY), while the FY2020 annual figure was $330.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q2 2021 stood at $330.0 million, roughly flat from $330.0 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $330.0 million in Q3 2020, with the low at $280.0 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | CVRx | 76.63 Mn | 12.04 Mn | 13.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 329.98 Mn |
| Mar 31, 2021 | 329.98 Mn |
| Dec 31, 2020 | 329.98 Mn |
| Sep 30, 2020 | 329.98 Mn |
| Jun 30, 2020 | 279.98 Mn |